European Medicines Agency to discuss anaesthesia risk for weight-loss drugsThe European Medicines Agency (EMA) will assess the risk that patients on weight loss drugs such as semaglutide and tirzepatide may...
Novo Nordisk to protect US patients from unlawful sales of non-FDA approved ‘semaglutide medicines’Novo Nordisk is taking multiple actions to protect US patients from the unlawful marketing and sales of non-FDA approved counterfeit and...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment4 days ago